» Articles » PMID: 10695735

Molecular Pathogenesis of Multiple Sclerosis

Overview
Journal J Neuroimmunol
Specialty Neurology
Date 2000 Mar 1
PMID 10695735
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple sclerosis (MS) is best understood as an inflammatory disease of the central nervous system (CNS) white matter characterized by demyelination, focal T cell and macrophage infiltrates, axonal injury and loss of neurological function. Our current understanding invokes proinflammatory cells and mediators that may be triggered by environmental factors to mediate disease in a genetically susceptible host. Five major themes which have been associated with the pathogenesis of MS lesions will be discussed: (1) The differential activation states of myelin-reactive T cells from MS patients vs. normal individuals, (2) the selective expression of chemokines, adhesion molecules and matrix metalloproteinases, (3) the proposed roles of the B7 costimulatory pathway, (4) the proinflammatory cytokines and (5) the role of molecular mimicry.

Citing Articles

The role of inflammation in neurological disorders: a brief overview of multiple sclerosis, Alzheimer's, and Parkinson's disease'.

Cantero-Fortiz Y, Boada M Front Neurol. 2024; 15:1439125.

PMID: 39539666 PMC: 11558529. DOI: 10.3389/fneur.2024.1439125.


Zinc Toxicity: Understanding the Limits.

Schoofs H, Schmit J, Rink L Molecules. 2024; 29(13).

PMID: 38999082 PMC: 11243279. DOI: 10.3390/molecules29133130.


Multiple Sclerosis: Therapeutic Strategies on the Horizon.

Manjunatha R, Habib S, Sangaraju S, Yepez D, Grandes X Cureus. 2022; 14(5):e24895.

PMID: 35706718 PMC: 9187186. DOI: 10.7759/cureus.24895.


Activation of Transcription Factor 4 in Dendritic Cells Controls Th1/Th17 Responses and Autoimmune Neuroinflammation.

Manoharan I, Swafford D, Shanmugam A, Patel N, Prasad P, Thangaraju M J Immunol. 2021; 207(5):1428-1436.

PMID: 34348977 PMC: 8415100. DOI: 10.4049/jimmunol.2100010.


Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy.

Orian J, DSouza C, Kocovski P, Krippner G, Hale M, Wang X Front Immunol. 2021; 12:620963.

PMID: 33679764 PMC: 7933211. DOI: 10.3389/fimmu.2021.620963.